Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Oncophage: Phase II

In a U.S. Phase II trial, 21 of 61 patients given Oncophage alone or

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE